Advertisement
Canada markets open in 3 hours 2 minutes
  • S&P/TSX

    22,373.38
    +52.51 (+0.24%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.29 (+0.01%)
     
  • CAD/USD

    0.7337
    +0.0000 (+0.00%)
     
  • CRUDE OIL

    78.95
    +1.23 (+1.58%)
     
  • Bitcoin CAD

    93,504.23
    +121.53 (+0.13%)
     
  • CMC Crypto 200

    1,487.00
    -9.46 (-0.63%)
     
  • GOLD FUTURES

    2,344.80
    +10.30 (+0.44%)
     
  • RUSSELL 2000

    2,069.67
    +21.26 (+1.04%)
     
  • 10-Yr Bond

    4.4670
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,953.50
    +77.50 (+0.41%)
     
  • VOLATILITY

    12.39
    +0.03 (+0.24%)
     
  • FTSE

    8,303.47
    -14.12 (-0.17%)
     
  • NIKKEI 225

    38,855.37
    -44.65 (-0.11%)
     
  • CAD/EUR

    0.6743
    -0.0009 (-0.13%)
     

Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

CAMBRIDGE, Mass., May 02, 2024--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") will report its first quarter 2024 financial results on Thursday, May 9, 2024. Amylyx’ senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.

To access the conference call, please dial +1 (877)-346-6112 (U.S. & Canada) or +1 (848)-280-6350 (international) at least 10 minutes prior to the start time and ask to be joined into the Amylyx Pharmaceuticals call. A live audio webcast of the call will be available under "Events and Presentations" in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events. The webcast will be archived and available for replay for 90 days following the event.

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts. For more information, visit amylyx.com and follow us on LinkedIn and X, formerly known as Twitter. For investors, please visit investors.amylyx.com.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240502818836/en/

Contacts

Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com

Investors
Lindsey Allen
Amylyx Pharmaceuticals, Inc.
+1 (857) 320-6244
Investors@amylyx.com